The Influence of Verapamil on Cardiac Uptake of I-123 Labelled Anthracyclines in Rabbits
Winfried Brenner, Karl Dietrich Erdmann, Marcel König, H. Wolf, K. H. Bohuslavizki, Jens Eberhardt, Michael P. Schramm, M. Clausen, E. Henze
Abstract
Winfried Brenner, Karl Dietrich Erdmann, Marcel König, H. Wolf, K. H. Bohuslavizki, Jens Eberhardt, Michael P. Schramm, M. Clausen, E. Henze
Abstract
Since verapamil has been shown to increase cellular concentrations of anthracyclines in resistant tumor cells, this study was designed to investigate the impact of verapamil on myocardial accumulation of I-123 labelled doxorubicin (DOX) and iodo-doxorubicin (IDOX) in rabbits and to estimate the risk of increasing anthracycline-related cardiotoxicity. Cardiac accumulation of both DOX and IDOX, calculated by scintigraphic means, neither confirmed major differences due to prior administration of verapamil nor an increased risk of cardiotoxicity of DOX and IDOX in combination with verapamil, respectively.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Since verapamil has been shown to increase cellular concentrations of anthracyclines in resistant tumor cells, this study was designed to investigate the impact of verapamil on myocardial accumulation of I-123 labelled doxorubicin (DOX) and iodo-doxorubicin (IDOX) in rabbits and to estimate the risk of increasing anthracycline-related cardiotoxicity. Cardiac accumulation of both DOX and IDOX, calculated by scintigraphic means, neither confirmed major differences due to prior administration of verapamil nor an increased risk of cardiotoxicity of DOX and IDOX in combination with verapamil, respectively.
Key concepts: Verapamil, Cardiotoxicity, Anthracycline, Doxorubicin, Pharmacology, Medicine, Chemotherapy, Daunorubicin